Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07143734
PHASE2

Transcranial Pulse Stimulation for Alzheimer's Disease

Sponsor: Chinese University of Hong Kong

View on ClinicalTrials.gov

Summary

TPS is a non-invasive therapeutic modality that uses focused, low-energy pulse stimulation to stimulate tissue regeneration and reduce inflammation. In the context of neurological disorders, it is hypothesized that TPS can modulate neuronal activity, enhance synaptic plasticity, and reduce neuroinflammation. It is a relatively new application in neurological disease treatment and is still under intense investigation.

Official title: A Pilot Randomized Placebo-Controlled Trial of Transcranial Pulse Stimulation (TPS) in Early Alzheimer's Disease (AD) Subjects

Key Details

Gender

All

Age Range

60 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-07-21

Completion Date

2026-06

Last Updated

2025-09-16

Healthy Volunteers

No

Interventions

DEVICE

transcranial pulse stimulation (TPS)

The TPS/Sham-TPS therapy is administered for the first two weeks, followed by additional sessions at some week intervals.

DEVICE

transcranial pulse stimulation (TPS-Sham)

Participants will undergo an identical procedure using a device that mimics the sound and sensation of active TPS but delivers no therapeutic energy pulses to the brain.

Locations (1)

Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese UNiversity of Hong Kong

Hong Kong, Hong Kong